Gene therapy for duchenne muscular dystrophy
AssigneeUniversity of Florida Research Foundation, Inc.
InventorHugh Lee Sweeney
Life of this patent
Estimating the term…
Abstract
The disclosure provides compositions and methods for producing micro-dystrophin proteins, and the use thereof (e.g., in gene therapy). The disclosure also provides skeletal muscle-specific promoters and the use thereof (e.g., in gene therapy). The disclosure further provides catheter-based methods of delivering gene therapy vectors to skeletal muscle and/or cardiac muscle.
Claims88
A recombinant nucleic acid comprising a nucleotide sequence encoding a micro-dystrophin protein comprising a utrophin N-terminus.
The recombinant nucleic acid of any preceding claim, wherein the nucleic acid comprises one or more nucleotide sequences of any one of SEQ ID NOs:
- 70, 72, and 207-247.
The recombinant nucleic acid of any preceding claim, wherein the nucleic acid comprises at least two, at least three, at least four, or at least five nucleotide sequences of any one of SEQ ID NOs:
- 70, 72, and 207-247.
The recombinant nucleic acid of any preceding claim comprising a promoter that is operably linked to the nucleotide sequence encoding the micro-dystrophin protein.
The recombinant nucleic acid of any preceding claim, wherein the micro-dystrophin protein encoded by the nucleic acid comprises an amino acid sequence that is at least 80% identical to the amino acid sequence of any one of SEQ ID NOs:
- 1-6 and 13-21.
The recombinant nucleic acid of any preceding claim, wherein the micro-dystrophin protein encoded by the nucleic acid comprises the amino acid sequence of any one of SEQ ID NOs:
- 1-6 and 13-21.
The method of any one of 32-61, wherein the micro-dystrophin protein encoded by the vector of the first or second rAAV particle comprises the region of dystrophin from spectrin-like repeat 24 to the C-terminus.
The method of 71, wherein the vasodilator is a PDE5 inhibitor.
A chimeric protein comprising an amino acid sequence having at least 90%, 95%, 98%, or 99% sequence identity to of any one of SEQ ID NOs:
- 81-84, 93-101 and 149-155.
A chimeric protein comprising the amino acid sequence of any one of SEQ ID NOs:
- 81-84, 93-101 and 149-155.
A recombinant nucleic acid comprising a nucleotide sequence encoding a micro-dystrophin protein comprising a utrophin N-terminus, wherein the nucleic acid comprises a sequence having at least 85%, 90%, 95%, 98%, or 99% sequence identity to of any one of SEQ ID NOs 85-92.
Dependencies are inferred from the claim text.